arrow
S

Steven Collins

assistance publique hopitaux paris (aphp)
H指数:71
被引数:2.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development of a user guide to support administration of the MRC Prion Disease Rating Scale in research and clinical settings for prion diseases

为朊病毒疾病研究及临床环境中朊病毒疾病评分量表(MRC Prion Disease Rating Scale)的管理提供支持的《用户指南》的开发

Prion
IF1.6
2025-12-310
PRE
Plasma p-tau217, NfL, GFAP diagnostic performance and biomarker profiles in Alzheimer's disease, frontotemporal dementia, and psychiatric disorders, in a prospective unselected neuropsychiatry memory clinic

血浆p-tau217、NfL、GFAP在阿尔茨海默病、额颞叶痴呆和精神障碍中的诊断性能及生物标志物特征,在一项前瞻性、非选择性的神经精神科记忆门诊研究。

2025-09-300
OAAI
Multiomic analyses direct hypotheses for Creutzfeldt-Jakob disease risk genes

多组学分析指导克雅氏病风险基因的假设提出

Brain
IF11.7
2025-01-270
OA
Plasma and CSF neurofilament light chain distinguish neurodegenerative from primary psychiatric conditions in a clinical setting

在临床环境中,血浆和CSF神经丝轻链可区分神经退行性病变和原发性精神病

2024-10-062
OA
Plasma p-tau181/Aβ1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ1-42 and future cognitive decline

血浆p-tau181/Aβ1-42比值可预测a β-pet状态,并与CSF-p-tau181/Aβ1-42和未来认知能力下降相关

2022-11-257
OAAI
Cerebrospinal fluid neurofilament light chain differentiates behavioural variant frontotemporal dementia progressors from non-progressors

脑脊液神经丝轻链区分行为变异额颞叶痴呆进展者与非进展者

2022-11-0112
OAAI
Insulin resistance, cognition and Alzheimer's disease biomarkers: Evidence that CSF A,B42 moderates the association between insulin resistance and increased CSF tau levels

胰岛素抵抗,认知和阿尔茨海默病生物标志物: CSF A,B42调节胰岛素抵抗与CSF tau水平升高之间关系的证据

2022-06-018
PRE
Diagnostic accuracy of cerebrospinal fluid biomarkers in genetic prion diseases

脑脊液生物标志物在遗传性朊病毒病中的诊断准确性

BRAIN
IF11.7
2022-03-1520
OAAI
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings

脑脊液神经丝轻链在临床环境中将原发性精神疾病与快速进展的阿尔茨海默病和额颞叶疾病区分开来

2022-02-0125
OA